The Guy’s and St Thomas’ NHS Foundation Trust Board holds legal accountability for the Trust, including Evelina London Women's and Children's Clinical Group.
Evelina London Women's and Children's Clinical Group is one of four clinical groups within the Trust.
As a clinical group our leadership team has formally devolved responsibility for services for women, children and young people, and has a significant degree of delegated authority.
We organise ourselves into five clinical directorates which have their own management teams:
- Children’s Medicine and Neonatology
- Children’s Surgery, Theatres and Anaesthesia
- Children’s Cardio-respiratory and Intensive Care
- Children’s Community Services
- Women’s Services
Find out more about our services for women and children.
The vision for our services is 'excellent care, healthier lives'. Our online strategy document for more information about our strategic priorities.
The Evelina London Women's and Children's Clinical Group Board
Our advisory Board provides expert advice and independent challenge to our executive team about operational matters, quality and safety, financial performance and strategy. It also serves to makes sure that the experience of our patients and families remains central to our decision making.
The role of our Board is to:
- ensure the clinical group is operating within the Trust's strategic and operational framework in alignment with the Evelina London strategy
- provide external advice and independent challenge.
- monitor operational, quality and safety, financial performance and key risks and issues
- Professor Deirdre Kelly CBE (Chair), Non-executive Director of the Guy’s and St Thomas’ NHS Foundation Trust Board
- Professor Miranda Brawn, Non-executive Director of the Guy’s and St Thomas’ NHS Foundation Trust Board
- Avey Bhatia, Chief Nurse and Executive Director on the Guy's and St Thomas' NHS Foundation Trust Board
- Jon Findlay, Chief Operating Officer, Guy’s and St Thomas’
- Dr Simon Steddon, Chief Medical Officer
- Crystal Akass, Chief People Officer
- Jackie Parrott, Chief Strategy Officer
Non-executive advisors provide specialist knowledge, expertise and advise to help inform Board discussions.
Kate Denham
Kate Denham is an experienced non-executive and service user advocate. She is a Non-Executive Director for the Coal Authority, and for Transport Focus, focusing on the passenger experience. She is also a member of the Office of Rail and Road Consumer Expert Panel and a trustee for Coeliac UK. She was previously a board member for an organisation supporting individuals with complex mental health needs, a nurse-led social enterprise delivering NHS services in east London, and Healthwatch - championing patient experience at local level. Alongside her board roles, Kate works across health and non-profit organisations on strategy and transformation projects. Kate's 2 children were born at St Thomas' Hospital and one continues as an Evelina London patient.
Professor Tim Barrett
Professor Tim Barrett is a children's doctor specialising in hormones and diabetes, professor of paediatrics at the University of Birmingham, an NIHR Senior Investigator and research director for NHS England Central and South Genome Medicine Service. Tim brings a wealth of clinical academic experience. He has been involved in the establishment of specialist services, served on a number of advisory and guideline committees and written chapters in 9 books. His main research focus has been in clinical trials in rare diseases and addressing health inequalities in children with diabetes.
Professor Dame Lesley Regan
Professor Dame Lesley Regan has a 40-year career as an obstetrician, gynaecologist and advocate for the pivotal importance of women's health in our society. She has combined her front-line clinical roles with several influential leadership roles. These include being President of the Royal College of Obstetricians and Gynaecologists, Honorary Secretary of the International Federation of Gynaecology and Obstetrics, chairing the Wellbeing of Women charity and serving as a non-executive director for NHS Resolution to advise on maternity improvement. She also co-chaired the Department of Health and Social Care's Women's Health Taskforce between 2018 and 2020. She became the first Women's Health Ambassador for England in June 2022 to help implement the Women's Health Strategy nationally.
Professor Meriel Jenney
Professor Meriel Jenney has over 30 years' experience as a consultant paediatric oncologist. Her main research interests are in rhabdomyosarcoma, the assessment of quality of life of children with cancer and the late effects of treatment for children with cancer and she has co-authored over 50 publications. She retired from her role as Executive Medical Director for Cardiff and Vale University Health Board in March 2024 and was a Trustee of Clic Sargent (now Young Lives v Cancer) for over 12 years. Meriel continues to support the development of paediatric oncology services in Sierra Leone.
The following member of the Guy’s and St Thomas’ Council of Governors attends the Evelina London Women’s and Children’s Clinical Group Board.
- Gubby Ayida, Chief Executive
- Dr Sara Hanna, Medical Director
- Janet Powell, Director of Nursing
- Miranda Loveday, Chief Children's Allied Health Professionals and Psychology
- James O’Brien, Director of Operations and Improvement
- Cheryl Samuels, People Director
- Kate Jones, Director of Strategy
- Gina Brockwell, Chief Midwife
- Stephanie Hendrickson, Head of Finance
- Andi Ttofa, Head of Communications
- Charlotte Dunn, Chief of Staff
The Evelina London Women's and Children's Clinical Group Executive Committee
The Executive Committee has overall responsibility for ensuring the safety, quality, effectiveness and financial sustainability of all our services for women, children, young people and their families. It is the most senior level decision making committee within the clinical group.
There are 6 sub-committees which are authorised to make decisions on matters referred by the Executive Committee. These sub-committees cover: operations, people, change portfolio management and resources, patient experience, clinical governance, research and innovation.